Completed PHASE2 INTERVENTIONAL 1-arm NCT01807546

Oral Rigosertib for Squamous Cell Carcinoma

A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma

Sponsor: Traws Pharma, Inc.

Conditions Anal Squamous Cell Carcinoma Cervical Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma Lung Squamous Cell Carcinoma Penile Squamous Cell Carcinoma Skin Squamous Cell Carcinoma

Interventions rigosertib

Updated 9 times since 2017 Last updated: Jun 22, 2017 Started: Mar 31, 2013 Primary completion: Mar 31, 2015 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anal Squamous Cell Carcinoma and Cervical Squamous Cell Carcinoma, this trial is completed. The trial is conducted by Traws Pharma, Inc. and has accumulated 9 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jun 2024 — Jul 2024 [monthly]

Completed PHASE2
Apr 2022 — Jun 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Aug 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Aug 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Traws Pharma, Inc.

Data source: Traws Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Aurora, United States , Columbus, United States , Dallas, United States , Denver, United States , East Orange, United States , Fairfax, United States , New York, United States , Philadelphia, United States , Sacramento, United States and 3 more locations